Why Curaleaf Stock Is Crushing It Today

Key Points

• Curaleaf's Q2 numbers weren't all that impressive.

• However, the U.S. market showed some signs of stabilization.

• Curaleaf's international business is booming.

• 10 stocks we like better than Curaleaf ›

Shares of Curaleaf Holdings (OTC: CURLF) were jumping 13.2% higher at 11:11 a.m. ET on Monday. The big gain appeared to be due to continued momentum for the Connecticut-based cannabis company after it announced second-quarter results following market close on Wednesday, Aug. 6.

Since Curaleaf's Q2 update, its share price has soared more than 20%. The marijuana stock is up almost 180% since it announced the buyout of its minority partner in Curaleaf International.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

How good were those Q2 results?

But Curaleaf's Q2 update didn't seem all that great -- at least, not at first glance.

The company's net revenue tumbled 8% year over year to $314.5 billion. Its net loss from continuing operations worsened, from $48.6 million in the second quarter of 2024 to $50.6 million in the recent quarter. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) also fell by 9.7% year over year to $65.5 million.

But investors seem to be focusing on what appears to be stabilization in the U.S. cannabis market (domestic revenue increased from the first quarter of 2025) combined with Curaleaf's strong momentum in international markets. The company's international sales could grow even more thanks to its recently receiving a license to operate in Turkey.

Image source: Getty Images.

Is Curaleaf stock a buy?

I'm not convinced that Curaleaf stock is a great pick for most investors, though. The company remains unprofitable. It still faces headwinds in the U.S. market, which represents roughly 87% of total revenue. Perhaps Curaleaf's Q2 update momentum will continue, but I won't be surprised if the sizzle for this cannabis stock soon fizzles out.

Should you invest $1,000 in Curaleaf right now?

Before you buy stock in Curaleaf, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Curaleaf wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,119,863!*

Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of August 11, 2025

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.